Zymeworks Stock Quote ZYME - Stock Price, News, Charts, Message Board, Trades

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Current Price

14.9985

Bid

14.40

Ask

15.00

Volume

708,092

14.44 Day's Range 15.25

7.97 52 Week Range 17.70

Market Cap

1.033B

Previous Close

15.01

Open

15.25

Last Trade

14.7

Last Trade Time

Financial Volume

$ 10,569,782

VWAP

14.9271

Average Volume (3m)

515,972

Shares Outstanding

68,877,526

Dividend Yield

PE Ratio

-8.39

Earnings Per Share (EPS)

-1.72

Revenue

76.01M

Net Profit

-118.67M

Zymeworks Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development and commercialization of next-generation multifunctional biotherapeutics. Its suite of therapeutic platforms and its fully integrated drug development engine enable precise engineering of differentiat... Zymeworks Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development and commercialization of next-generation multifunctional biotherapeutics. Its suite of therapeutic platforms and its fully integrated drug development engine enable precise engineering of differentiated product candidates. Its lead clinical candidate, zanidatamab, is a novel Azymetric HER2-targeted bispecific antibody currently being evaluated in multiple Phase 1, Phase 2, and pivotal clinical trials globally as a targeted treatment option for patients with solid tumors that express HER2. The company is also advancing a deep preclinical pipeline in oncology and other therapeutic areas. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.zymeworks.com

Headquarters

Wilmington, Delaware, USA

Founded

Zymeworks Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker ZYME. The last closing price for Zymeworks was $15.01. Over the last year, Zymeworks shares have traded in a share price range of $ 7.97 to $ 17.70.

Zymeworks currently has 68,877,526 shares outstanding. The market capitalization of Zymeworks is $1.03 billion. Zymeworks has a price to earnings ratio (PE ratio) of -8.39.

Form 4 - Statement of changes in beneficial ownership of securities

Form 144 - Report of proposed sale of securities

Form 4 - Statement of changes in beneficial ownership of securities

Zymeworks Hosts R&D Day Highlighting Continued Clinical Progress in Oncology Programs and Expansion into Autoimmune and Inflammatory Diseases

Company on track to deliver five Investigational New Drug (IND) applications as part of ‘5 by 5’ solid tumor strategy 18 months ahead of original targetNomination of ZW209, a novel trispecific T...

Form 8-K - Current report

Zymeworks Announces Participation in Upcoming Investor Conferences

VANCOUVER, British Columbia, Nov. 21, 2024 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional...

FDA Grants U.S. Approval of Ziihera® (zanidatamab-hrii) for the Treatment of Adults with Previously Treated, Unresectable or Metastatic HER2-positive (IHC 3+) Biliary Tract Cancer (BTC)

Ziihera is the first and only dual HER2-targeted bispecific antibody approved for HER2-positive BTC in the U.S.Ziihera received accelerated approval based on results including a 52% objective...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.3885	2.659137577	14.61	17.07	13.771	555099	14.79326258	CS
4	0.8285	5.84685956246	14.17	17.07	12.43	558694	13.87232889	CS
12	1.7885	13.538985617	13.21	17.7	12.39	515972	14.33012229	CS
26	6.0985	68.5224719101	8.9	17.7	8.83	614339	12.39800222	CS
52	4.4385	42.03125	10.56	17.7	7.97	606209	11.17177166	CS
156	8.6185	135.086206897	6.38	17.7	6.015	619871	9.66475942	CS
260	8.6185	135.086206897	6.38	17.7	6.015	619871	9.66475942	CS

ZYME - Frequently Asked Questions (FAQ)

What is the current Zymeworks share price?

The current share price of Zymeworks is $ 14.9985

How many Zymeworks shares are in issue?

Zymeworks has 68,877,526 shares in issue

What is the market cap of Zymeworks?

The market capitalisation of Zymeworks is USD 1.03B

What is the 1 year trading range for Zymeworks share price?

Zymeworks has traded in the range of $ 7.97 to $ 17.70 during the past year

What is the PE ratio of Zymeworks?

The price to earnings ratio of Zymeworks is -8.39

What is the cash to sales ratio of Zymeworks?

The cash to sales ratio of Zymeworks is 13.1

What is the reporting currency for Zymeworks?

Zymeworks reports financial results in USD

What is the latest annual turnover for Zymeworks?

The latest annual turnover of Zymeworks is USD 76.01M

What is the latest annual profit for Zymeworks?

The latest annual profit of Zymeworks is USD -118.67M

What is the registered address of Zymeworks?

The registered address for Zymeworks is CORPORATION TRUST CENTER, 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801

What is the Zymeworks website address?

The website address for Zymeworks is www.zymeworks.com

Which industry sector does Zymeworks operate in?

Zymeworks operates in the PHARMACEUTICAL PREPARATIONS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
BOXLBoxlight Corporation	$ 1.645 (257.61%)	240.37M
SPRCSciSparc Ltd	$ 1.06 (100.80%)	189.16M
XTIAXTI Aerospace Inc	$ 0.08261 (99.54%)	1.55B
DHAIDIH Holdings US Inc	$ 2.8602 (82.18%)	4.63M
NXPLNextPlat Corporation	$ 1.73 (61.68%)	12.6M
RGFReal Good Food Company Inc	$ 1.31 (-63.49%)	1.47M
LUNALuna Innovations Incorporated	$ 0.8744 (-57.35%)	12.25M
GCTKGlucoTrack Inc	$ 0.1594 (-45.65%)	35.5M
ACONAclarion Inc	$ 0.1699 (-43.06%)	34.75M
BLRXBioLineRx Ltd	$ 0.1621 (-40.80%)	43.2M
XTIAXTI Aerospace Inc	$ 0.08261 (99.54%)	1.56B
NVDANVIDIA Corporation	$ 149.43 (3.43%)	264.32M
CNSPCNS Pharmaceuticals Inc	$ 0.11987 (-2.54%)	246.67M
BOXLBoxlight Corporation	$ 1.645 (257.61%)	240.38M
SPRCSciSparc Ltd	$ 1.06 (100.80%)	190.41M